|
|
楼主 |
发表于 2025-1-9 17:21:59
|
显示全部楼层
还统计少了，华西医院牵头是25项
w5 w6 x. T8 ]01.Risk factors of complications after inguinal lymph node dissection in patients with penile cancer.
3 {' e5 ^, I* s6 L7 P9 h02.Tislelizumab in combination with abiraterone/enzalutamide for metastatic castration-resistant prostate cancer with intraductal adenocarcinoma of the prostate after progression on prior androgen receptor pathway inhibitor./ Q- w- \# }( [: p/ x5 N0 M5 ^* V4 A6 m
03.Discordance in HER2 expression in primary and recurrent/metastatic lesions of upper tract urothelial carcinoma: A study focusing on temporal heterogeneity.( \2 x. F4 S- T" u9 h% Q9 }
04.The impact of neoadjuvant therapy on the formation of tertiary lymphatic structures and the distinct prognosis in prostate cancer.
G# A$ W0 {7 S05.Phenotypic and genetically predicted leukocyte telomere length and prostate cancer risk: Results from a large-scale longitudinal cohort study.: Z8 \/ u; a. n9 D, t: l3 A
06.Survival impact of concomitant squamous differentiation in upper tract urothelial carcinoma patients receiving adjuvant chemotherapy." ~2 i; i* o# D+ t; y( T
07.Pathological subclassification of T3 upper tract urothelial carcinoma: Complementary evidence for existing guidelines.
& ^0 F$ `" ~- _$ r. H' x! B08.Evaluating the efficacy and safety of pelvic lymph node dissection in high-risk prostate cancer patients undergoing radical prostatectomy: A systematic review and meta-analysis.7 n [, H5 h6 P0 k
09.Safety and efficacy of immune checkpoint inhibitor rechallenge in metastatic fumarate hydratase-deficient renal cell carcinoma: A retrospective study.) W' k! k5 }4 c5 w: Q
10.Interpretable machine learning for prostate biopsy: Cohort study.( O2 j: Q; C$ v9 L4 N F
11.Genomic features of prostate cancer patients with and without ductal adenocarcinoma (DA) based on liquid biopsy./ t! T( T4 Y7 [0 F2 R
12.Clinicopathological features and prognosis of MED15-TFE3 rearrangement renal cell carcinoma: An updated report.3 g7 b5 s' e, X+ r6 v7 w) ?1 J
13.Long-term results of a phase 2 study of neoadjuvant chemotherapy combined with tislelizumab followed by radiotherapy for bladder-preserving treatment in selected high-risk/locally advanced muscle invasive urothelial bladder cancer (HOPE-02).
' E E; p2 l' l+ Y. c0 M14.A multi-center phase Ib/II study of RC48-ADC combined with tislelizumab as neoadjuvant treatment in patients with HER2 positive locally advanced muscle-invasive urothelial bladder cancer (Hope-03).7 x: y8 O( T" { N+ m
15.VORSIN-RCC: Vorolanib plus sintilimab for advanced renal cell carcinoma after failure of prior immune checkpoint inhibitors-based combination therapy.6 i+ j$ [* F; l/ K( ^: Z1 H
16.Cadonilimab (anti-PD-1 and CTLA-4 bispecific antibody) combined with axitinib for the first-line treatment of advanced or metastatic non-clear renal cell carcinoma: A prospective, single-arm, phase Ib/II study.+ F1 L, k' C% G: V
17.Kidney-sparing approach for selected localized high-risk upper tract urothelial carcinoma: A pilot study combining endoscopic thulium laser ablation with perioperative disitamab vedotin and immune checkpoint inhibitors." R5 U* l0 |. B; R( b
18.Comprehensive modalities of kidney-sparing treatment in a carefully selected cohort of localized high-risk upper tract urothelial carcinoma: A potential paradigm shift.
* S, ^! k% u3 p6 j! i4 j19.Efficacy of systemic treatments for advanced non-clear cell renal cell carcinoma: A single-arm systematic review and meta-analysis.9 w8 J% z3 ~& a1 i t
20.The prognostic significance of prostate-specific antigen dynamics during abiraterone therapy in patients with high-risk metastatic hormone-sensitive prostate cancer.1 B O9 Z% E# _, m2 D1 J5 {, J
21.Global spatiotemporal trends in prostate cancer burden and its socioeconomic disparities: An observational study from 1990 to 2021.
6 K: P9 m: q1 b* @7 F6 z22.Optimizing the strategies to perform prostate biopsy in MRI-positive patients: A systematic review and network meta-analysis.
; X- U& J$ P- _1 k X23.Assessment of the proficiency of ChatGPT-4o in an image-based robot-assisted radical prostatectomy scenario.1 G5 ?( V7 y$ x+ j) u1 c1 N
24.The prognostic significance of circulating tumor DNA in prostate cancer: A systematic review and meta-analysis.8 f& m3 X q8 s4 p( U3 n/ }
25.Global and regional burden of kidney cancer: Analysis and future predictions based on GBD data from 1990 to 2021.
, F6 H6 e8 ~( k" H0 C |
|
发表于 2025-1-9 15:59:44
发表于 2025-1-9 17:01:32
看年内重离子质子医院投运后，能否发起追赶
